This study is considering current standard oxytocin dosing regimen in combination with Foley
bulb for cervical ripening is associated with improved outcomes including greater percentage
of women delivered within or less than 24 hours. The investigators will also assess other
maternal and neonatal outcomes including risk of infection (i.e. chorioamnionitis), bleeding,
uterine atony, cesarean delivery and use of regional analgesia.
Participants will be randomly assigned to one of the 2 arms of the study: use of oxytocin or
no oxytocin while the Foley bulb is in place. As part of standard of care for inductions,
Foley bulbs will be placed for all participants. Study participants who are randomly assigned
to the use of oxytocin will receive oxytocin at the time the Foley bulb is placed. Study
participants randomly assigned to no oxytocin will receive the oxytocin once the Foley bulb
is removed.
After delivery, information will be collected from participant's chart on the outcome of
pregnancy such as gestational age at delivery, type of delivery (vaginal or cesarean
section), and baby's outcome (such as birth weight, APGAR scores, and any complications).